Negotiated reimbursement rates for D1354 across 29 states, sourced from CMS Transparency in Coverage data. 157 rate records.
D1354 refers to the application of an Interim Caries Arresting Medicament, such as silver diamine fluoride (SDF), which is used to halt the progression of carious lesions. This procedure is clinically indicated for patients with active caries who may not be able to undergo traditional restorative treatment. Documentation must include the rationale for using SDF, the teeth treated, and patient consent. Reimbursement for D1354 can vary widely among payors and states, with some plans recognizing it as a preventive measure while others may not. The average reimbursement for this service is about $48.
Reimbursement rates for D1354 vary significantly by state, payor, and provider network. The national average negotiated rate is $48. Data sourced from CMS Transparency in Coverage machine-readable files, updated monthly.
26+ more states available with Pro ↓